Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium Hyaluronate 0.18% in Dry Eye Syndrome
NCT01382225Phase 3Completed
- Sponsor
- Alcon Inc.
- Start
- Jul 2011
- Primary completion
- May 2012
- Modality
- Polymer-based Nanoparticles
01
Overview
A Phase 3 trial of Aili in dry eye syndrome (DED), sponsored by Alcon Inc.. Started Jul 2011; status: completed.
02
Drugs
Aili
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT01382225.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01382225.